Applied Biosciences Corp. (APPB)

Market Cap	2.14K -100.0%
Revenue (ttm)	859.86K +75.3%
Net Income	-2.79M
EPS	-0.20
Shares Out	21.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,450
Average Volume	6,656
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0001
Beta	2,174.97
RSI	47.39
Earnings Date	n/a

About Applied Biosciences

Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Employees: 25
• Stock Exchange: OTCMKTS
• Ticker Symbol: APPB

Financial Performance

In fiscal year 2019, Applied Biosciences's revenue was $707,062, an increase of 257.91% compared to the previous year's $197,554. Losses were -$2.63 million, 10.7% more than in 2018.